$65.3 Million is the total value of Invenire Partners, LP's 26 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MCS | Marcus Corp | $2,877,007,000 | -6.0% | 207,128 | 0.0% | 4.40% | +8.3% | |
| DNOW | NOW Inc | $2,706,967,000 | +2.8% | 269,350 | 0.0% | 4.14% | +18.3% | |
| PRIM | Primoris Services Corp | $2,364,375,000 | -25.3% | 145,500 | 0.0% | 3.62% | -14.0% | |
| TTEC | TTEC Holdings Inc | $2,245,719,000 | -34.7% | 50,682 | 0.0% | 3.43% | -24.8% | |
| SNCR | Synchronoss Technologies Inc | $1,390,310,000 | -0.9% | 1,219,571 | 0.0% | 2.13% | +14.2% | |
| BTTR | Better Choice Company Inc | $699,641,000 | -63.8% | 879,167 | 0.0% | 1.07% | -58.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DHI Group Inc | 4 | Q3 2022 | 7.9% |
| Tetra Technologies Inc | 4 | Q3 2022 | 6.5% |
| Harrow Health Inc | 4 | Q3 2022 | 8.4% |
| TTEC Holdings Inc | 4 | Q3 2022 | 5.9% |
| Clarus Corp | 4 | Q3 2022 | 5.9% |
| Apyx Medical Corp | 4 | Q3 2022 | 6.5% |
| InfuSystem Holdings Inc | 4 | Q3 2022 | 5.1% |
| PAR Technology Corp | 4 | Q3 2022 | 4.9% |
| Cantaloupe Inc | 4 | Q3 2022 | 5.2% |
| Marcus Corp | 4 | Q3 2022 | 4.4% |
View Invenire Partners, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2023-03-31 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| D/A | 2019-03-12 |
| D | 2018-01-02 |
View Invenire Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.